No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Reduced intensity chemotherapy improves quality of life without reducing survival in frail or elderly patients with gastroesophageal cancer

byTeddy Guo

September 4, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract Anakinra was not superior to placebo in treating palmoplantar pustulosis (APRICOT)

RelatedReports

Development of a risk index for colorectal cancer screening

Chronic Disease

Sequential compared to upfront treatment of metastatic colorectal cancer using oxaliplatin (Eloxatin) therapy may lead to similar outcomes

May 12, 2026

Survivors of adult-onset cancers associated with increased incidence of cardiovascular disease

Oncology

Neoadjuvant therapy regimen improves outcomes in high-risk intrahepatic cholangiocarcinoma

March 18, 2026

Bilateral diagonal earlobe creases associated with increased risk of coronary artery disease

Chronic Disease

Short-course personalized acoustic therapy may increase tinnitus remission in patients with idiopathic sudden sensorineural hearing loss

January 13, 2026

Gastric bypass surgery reduces cardio-metabolic risk factors

Chronic Disease

Endoscopic sinus surgery improves quality of life compared with clarithromycin and placebo in chronic rhinosinusitis

October 28, 2025

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Substantial prevalence of transthyretin amyloid cardiomyopathy present in patients with heart failure with preserved ejection fraction

Galcanezumab reduces the frequency of episodic cluster headaches

More omega-3 and less omega-6 fatty acid consumption associated with reduced migraine frequency and severity

$#VisualAbstract Obinutuzumab-atezolizumab-lenalidomide is effective and tolerable in patients with relapsed/refractory follicular lymphoma$

#VisualAbstract Obinutuzumab-atezolizumab-lenalidomide is effective and tolerable in patients with relapsed/refractory follicular lymphoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Reduced intensity chemotherapy improves quality of life without reducing survival in frail or elderly patients with gastroesophageal cancer

RELATED REPORTS

#VisualAbstract Anakinra was not superior to placebo in treating palmoplantar pustulosis (APRICOT)

Substantial prevalence of transthyretin amyloid cardiomyopathy present in patients with heart failure with preserved ejection fraction

RelatedReports

Recent Reports